Conversely, combined TP53 and RB1 loss may confer PARPi resistance, which might be overcome by the combination of PARP and ATR inhibition, exploiting the vulnerability of PCa cells with combined TP53 and RB1 loss to replication stress. This evidence concerns the gene RB1 and posterior cortical atrophy.